We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
This guidance covers ‘grandfathering’ and managing the lifecycle changes of medicinal products.
Who in the pharmaceutical industry can be a Marketing Authorisation Holder, named distributor or local representative and how to make changes to these.
Apply for an authorisation to manufacture extemporaneous preparations, autogenous vaccines, stem cell products or blood products for non-food animals.
How to confirm a measles diagnosis, manage cases and contacts, control infection, and vaccinate young or partially-covered patients.
Placing a veterinary medicine on the market, including non-medicinal products, medicinal words and phrases, how to obtain advice, report non-compliance.
Information and resources on the UK’s plans to see antimicrobial resistance contained and controlled by 2040.
Data on the real-world efficacy of the COVID-19 vaccines.
Guidance on the handling of slurry and manure to help reduce the spread of antibiotic resistant bacteria.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
These temporary good manufacturing practice (GMP) flexibilities will be allowed to address the current exceptional circumstances
Up to £1.92 million funding available to develop capabilities that provide a competitive advantage to electromagnetic targeting and defence
Draft of a proposed Remedial Order to amend the State Immunity Act 1978 (c. 33) (the “SIA”) to allow a category of claimants to bring employment claims against their diplomatic mission or consular post employers.
For manufacturers and distributors of intermediate and final feedingstuffs containing a medicinal premix or specified feed additives.
VDEC responds strategically to AMR pathogens and new emerging threats (fungi, viruses, and bacteria), by determining the most appropriate research goals to combat these pathogens
These published standards relate to a number of KPIs in the VMD Deliverables and KPI document.
Guidance on the decentralised and mutual recognition reliance procedure (MRDCRP) for marketing authorisation applications including information on how to apply.
UK Health Security Agency's laboratories provide a comprehensive range of microbiological tests and services.
Funding of £85 million will be announced at a global event to support the international community in tackling the growing threat of antimicrobial resistance.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).